Results 61 to 70 of about 27,882,966 (366)

Mechanism of T cell regulation by microRNAs

Cancer Biology & Medicine, 2013
MicroRNAs (miRNAs) are small, non-coding single-stranded RNAs that can modulate target gene expression at posttranscriptional level and participate in cell proliferation, differentiation, and apoptosis. T cells have important functions in acquired immune
Juan Liu, Chang-Ping Wu, Bin-Feng Lu, Jing-Ting Jiang   +3 more
doaj   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine, Hallie Coltin, Maria Kondyli, Monia Marzouki, Nicolas Prud'homme, Nida Usmani, Rebecca J. Deyell, Lesleigh Abbott, Tony H. Truong, Sapna Oberoi, Ketan Kulkarni, Josée Brossard, Lynette Bowes, Paul Gibson, Sarah McKillop, Roona Sinha, Lillian Sung, Catherine Vezina, Laura Wheaton, Alexandra P. Zorzi, Marie‐Claude Pelland‐Marcotte, Thai Hoa Tran   +21 more
wiley   +1 more source

Biological wastewater treatment systems: an overview

, 2023
Overpopulation, industrialization, and unregulated discharge result in the occurrence of the contaminants in water bodies, which calls for treatment technologies.
Ngo, HH, Nguyen, Q-H, Le, L-T, Bui, X-T, Nguyen, DD, Nguyen, P-D, Pandey, A   +6 more
core   +1 more source

Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer

Journal of Experimental & Clinical Cancer Research, 2019
Background Evidence suggests that fatty acid receptor FFAR4 plays a tumor-promoting role in adipose tissue-adjacent malignancies, but its clinical relevance remains unexplored.
Xiao Chu, Qi Zhou, Yingchun Xu, Jingting Jiang, Qing Li, Qianjun Zhou, Qiong Wu, Min Jin, Hui Wang, Yuting Gu, Xue Wang, Bei Wang, Songbing He, Xiaozhou He, Changping Wu, Fengchun Zhang, Yanyun Zhang   +16 more
doaj   +1 more source

The Performance of Net-Like Rotating Biological Contactor Bioreactor in Removal of Sulfamethoxazole Antibiotic [PDF]

آب و فاضلاب, 2019
Pharmaceutical wastewater treatment is a complicated process due to presence of various kinds of toxic chemicals and antibiotics that are harmful to any type of organisms.
Nastaran Azimi, Maedeh Sadeghpour Haji, Saeid Khalili   +2 more
doaj   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, Xiaocui Zhang   +5 more
wiley   +1 more source

Biologic Agents for the Treatment of Anaphylaxis

Immunology and Allergy Clinics of North America, 2020
Several biologic therapies and new devices are emerging as potential preventive treatment of anaphylaxis. However, adrenaline (epinephrine) is still the first-line treatment of any type of anaphylaxis. Biologic drugs, such as omalizumab, although not US Food and Drug Administration approved for anaphylaxis, have been used as therapeutic adjuvants in ...
Tanno, Luciana Kase, Martin, Bryan
openaire   +2 more sources

Off-label use of rituximab in dermatology: pemphigus treatment [PDF]

Anais Brasileiros de Dermatologia, 2013
Since its approval in 1997 by the FDA (United States Food and Drug Administration), rituximab has been used for certain B-cell lymphomas and treatment-resistant rheumatoid arthritis.
Lislaine Bomm, Tainá Scalfoni Fracaroli, João Luz Sodré, Aline Bressan, Alexandre Carlos Gripp   +4 more
doaj   +1 more source

Effect of DFPP on Ferroptosis in Peripheral Blood CD14+ Monocytes of Hyperlipidemic Patients Involving the ACSL4/LPCAT3/ALOX5 Pathway

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng, Lan Li, Qingmei Yang, Meipeng Wu   +3 more
wiley   +1 more source

Biologically Based Treatment Planning [PDF]

Acta Oncologica, 1999
The classical way of quantifying dose-response relations for tumors and normal tissues and their dependence on the genetic make up of the patient is briefly reviewed. Response quantifiers such as quality of life and the probability of achieving a complication-free cure are helpful in solving many of the problems of radiation therapy planning.
openaire   +2 more sources